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High fat diet significantly changed the
global gene expression profile involved in
hepatic drug metabolism and
pharmacokinetic system in mice
Yuqi He1,2, Tao Yang1, Yimei Du1, Lin Qin1, Feifei Ma1, Zunping Wu1, Hua Ling3, Li Yang2, Zhengtao Wang2,
Qingdi Zhou4, Guangbo Ge1,5* and Yanliu Lu1,2*
Abstract
Background: High fat diet impact transcription of hepatic genes responsible for drug metabolism and pharmacokinetics.
Until now, researches just focused on a couple specific genes without a global profile showing. Age-dependent manner
was also not noted well. This study aims to investigate the high fat diet effect on transcriptome of drug metabolism and
pharmacokinetic system in mouse livers and show the age-dependent evidence.
Methods: C57BL/6 male mice were used in this experiment. High fat diet was used to treat mice for 16 and 38weeks.
Serum total cholesterol, low density lipoprotein cholesterol, aspartate transaminase, and alanine transaminaselevels
were measured. Meanwhile, Histology, RNA-Seq, RT-PCR analysis and fourteen major hepatic bile acids quantification
were performed for the liver tissues. Data was mined at levels of genes, drug metabolism and pharmacokinetic sysem,
and genome wide.
Results: Treatment with high fat diet for 38 weeks significantly increased levels of serum lipids as well as aspartate
transaminase, and alanine transaminase. Meanwhile, lipid accumulation in livers was observed. At week 38 of the
experiment, the profile of 612 genes involved in drug metabolism and pharmacokinetics was significantly changed,
indicated by a heatmap visulization and a principal component analysis. In total 210 genes were significantly regulated.
Cyp3a11, Cyp4a10, and Cyp4a14 were down-regulated by 10–35 folds, while these three genes also were highly
expressed in the liver. High fat diet regulated 11% of genome-wide gene while 30% of genes involved in the hepatic
drug metabolism and pharmacokinetic system. Genes, including Adh4, Aldh1b1, Cyp3a11, Cyp4a10, Cyp8b1, Fmo2,
Gsta3, Nat8f1, Slc22a7, Slco1a4, Sult5a1, and Ugt1a9, were regulated by high fat diet as an aging-dependent manner.
Bile acids homeostasis, in which many genes related to metabolism and transportation were enriched, was also
changed by high fat diet with an aging-dependet manner. Expression of genes in drug metabolism and disposition
system significantly correlated to serum lipid profiles, and frequently correlated with each other.
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Conclusions: High fat diet changed the global transcription profile of hepatic drug metabolism and pharmacokinetic
system with a age-dependent manner.
Keywords: High fat diet, Drug metabolism and pharmacokinetic, RNA-Seq, Transcriptome
Background
Precision medicine has the potential to change the prac-
tice of medicine by tailoring treatments to individuals.
By giving a patient with the right drug at the right dos-
age with a right form at a right time, the health care
could be delivered with greater accuracy and efficiency,
leading to better health outcomes. In addition to how
molecules affect targets in human bodies, how human
bodies dispose xenobiotics is also important for precise
therapeutic effect. Once a molecule enters our biology
system, it may go through various metabolic process in-
cluding oxidation, hydrolysis, methylation, glucuronidation,
etc. Hundreds of enzymes and transporters participate in
these processes. As we know until now, the drug metabol-
ism and pharmacokinetic (DMPK) system includes a large
number of families such as cytochrome P450 (CYP), flavin-
containing monooxygenase (FMO), monoamine oxygenases
(MAO), esterases, UDP-glucuronosyltransferases (UGT),
methyltransferases (MET), APT binding cassettes (ABC),
and so on [1]. In different human body status, such as
physiological and various pathological conditions, the ex-
pression levels of these aforementioned proteins are chan-
gedaffected by the status of physiological and various
pathological conditions, and thenleading to the alterations
of the drug absorption, metabolism, transportation, and
eventually the pharmacokinetic profiles are altered. Thus, if
the expression levels of these enzymes and transporters
changed, the medication dosages and even the drug delivery
forms may have to be adjusted accordingly. Understanding
the change in DMPK system in various pathological sta-
tuses is the key step to guarantee the precision of the thera-
peutic effect.
Diets are one of the most important ways that humans
and animals exchange substances and energies with the
environment. A lot of diseases are caused by abnormal
and unhealthy diets. Among those unhealthy diets, high
fat diets are reported to be associated with various dis-
eases such as fatty liver diseases, diabetes, hyperlipid-
emia, hyperglycemia, atherosclerosis, and even neuron
system diseases. In the very beginning, high fat diet was
a label of traditional western food. However, with the
economy development, high fat diets become more
popular in China, Korea, Japan, and other eastern Asian
countries where vegetables and carbohydrates were the
traditional foods. Most of these diseases are associated
with functions of livers which is the most important
organ responsible for drug metabolism and disposition.
If the liver function changed, the expression levels of
genes or proteins in the DMPK system are altered ac-
cordingly. In vivo pharmacokinetic profile, such as bio-
availability, half life, and even tissue distribution, of
medicines treating these diseases would become abnor-
mal. Finally, the dosage and drug delivery system would
be re-designed to promise the effecacy and safety. Thus,
understanding the effect of high fat diets on DMPK sys-
tem is essential to guarantee the therapeutic precision.
The impairment on a couple DMPK genes expression
of caused by high fat diet has been reported in several
studies. Long term treatment of high fat diet significantly
reduced the mRNA levels of Cyp2a4, Cyp2b10, and
Cyp3a11, as well as their regulators such as nuclear re-
ceptors CAR, PXR, and RXR2. In the fatty liver diseases
rat model, gene expression levels of Cyp1a2, 2c11 and
3a2 were strongly reduced [2]. High fat and glucose diet
induced rat hepatic gene expression levels of Ugt1a6. In
high fat diet rat model, protein expression levels of
CYP2E1 and CYP4A were elevated [3], which could be
caused by the expression and activation of nuclear re-
ceptors CAR and PPARα [3]. In both patients and mur-
ine models with non-alcohol fatty liver diseases
(NAFLD), Cyp4a14 is up-regulated, while Cyp4a14
seems to be a therapeutic target of NAFLD [4]. How-
ever, for another fatty lipid catabolism enzyme Cyp4a10,
high fat diet significantly repressed its gene expression
[5]. In patients with non-alcohol steatohepatitis (NASH),
the serum arachidonic acid homeostasis mediated by
cytochrome P450 enzymes was completely dysregulated
[6]. Cyp7a1, Cyp8b1, and Cyp27a1, three important bile
acids biosynthesis enzymes, were up-regulated in pa-
tients with NAFLD [7]. In addition, transporters such as
NTCP (Slc10a1), OATP1B1, and OATP1B3, were also
up-regulated. Abnormal gene expression levels of CYPs
was not not only found in livers, but also in other tis-
sues. For example, gene expression levels of Cyp2j5,
Cyp2j6, and Cyp2c44 in adipose tissues were reduced by
high fat diet [8]. Accompanied with the effect on expres-
sion and activation of CAR and PPARα, UGT1A1 and
UGT1A6 expression levels were altered by the high fat
diet [3]. Regarding transporters, gene expression level of
Abcc3 was reduced by high fat diet [9].
Although data showed so many DMPK members regu-
lated by high fat diet, there are still some unsolved prob-
lems. For example, a research regarding high fat diet and
drug metabolizing enzymes revealed that high fat diet
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regulates endogenous CYPs in a gene-specific manner
[10]. Until now, hundreds of CYP isozymes have been
identified, but the effect of High fat diet effect on CYPs
has not been fully understood. On the other hand, other
than CYPs, the effect of high fat diet on other phase I
metabolizing enzymes such as MAO, NAT, esterases,
etc. is still not understood. Regarding phase II enzymes
and transporters, only a few of them were investigated.
We conducted a comprehensive literature and database
searchto collect more than 600 DMPK genes, unfortu-
nately, the understanding of the high fat diet effect on
most of those genes as well as on the global DMPK sys-
tem is still defficient.
Thus, in the present study, with a RNA-seq technol-
ogy, we investigated the transcriptome of mouse hepatic
DMPK system to profile the high fat diet induced
changes. In addtion, we also investigated age-dependent
impatct of high fat diet on a couple representative genes
involved in this system. We hope findings of the present
study would help the understanding of high fat diet ef-
fect on drug metabolism and disposition and help the
clinical study of the same topic.
Methods
Materials
Male C57BL/6 mice (23–25 g) were purchased from
Huafu Kang Biological Technology Co., Ltd. (Beijing,
China; approval number: SCXK 2014–0004). Standard
chow diet (23.2% of calories from protein, 12.1% from
fat, and 64.7% from carbohydrate) was purchased from
Jiangsu Xietong Biomedical Engineering Co., Ltd.
(Jiangsu, China). High fat diet (20.0% of calories from
protein, 60.0% from fat, and 20.0% from carbohydrate)
was purchased from Research Diets Inc. (New Brunswick,
USA). Total cholesterol assay kit, Low-density lipoprotein
cholesterol assay kit, Aspartate aminotransferase Assay
Kit, and Alanine aminotransferase Assay Kit were pur-
chased from Nanjing Jiangcheng Bioengineering Institute
(Nanjing, China). DEPC water was purchased from
Zoman Biotechnology Co., Ltd. (Beijing, China). Bile acid
was purchased from Sigma-Aldrich Co., Ltd. (St. Louis,
Missouri, United States). Ammonium acetate was pur-
chased from Thermo Fisher Scientific Co., Ltd. (Waltham,
Massachusetts, USA). Acetonitrile and methanol were
purchased from Tedia Co., Ltd. (Ohio, United States).
Animal experiments
Male C57BL/6 mice were kept in the well-controlled
animal room on the SPF (Specific Pathogen Free) level.
Room temperature was set to 21–23 °C, while the hu-
midity adjustment ranged from 50 to 60% and a 12 h
light/dark cycle was used. Animals were free to ingest
food and water, monitored body weight trends every
day. In this study, we involved 55 mice in total and set
three time points including day 0, week 16, and week 38.
At the start of the experiment, 11 mice in group day-0
were sacrificed without any treatment. The other 44
mice were divided into 4 groups (n = 11 per group),
treated by normal diet (ND) or high fat diet (HFD) for
16 or 38 weeks. At the end point of each group, mice
were anesthetized by 7% chloral hydrate (0.005 mL/g)
and blood was taken from the eyeball. After incubating
at room temperature for 1 h to obtain serum, blood was
centrifuged at 3500 rpm for 10 min to obtain serum. A
slice of liver samples was fixed in 10% formaldehyde so-
lution, while rest of the livers and other tissues were
placed in liquid nitrogen for quick-freezing, and then
stored in − 80 °C refrigerator. All mice were in accord-
ance with the requirements of Animal Experiment Ethics
Committee of Zunyi Medical University.
Histology analysis
The HE staining (hematoxylin and eosin staining) was
used to analyze histopathology of liver tissues. The liver
tissues were fixed in 10% formalin solution for 24 h,
dehydrated with alcohol and placed in xylene. The fixed
liver tissues was embedded in the paraffin (Leica
EG1150, Wetzlar, Germany) and then cut into slices of
6–8 μm by freezing microtome (Leica RM2245, Wetzlar,
Germany). Tissue slices were washed, dehydrated by
ethanol, and stained by hematoxylin and eosin for Olym-
pus BX43 microscopic examination (Tokyo, Japan).
Assays of serum cholesterol, glucose, ALT, and AST levels
Serum total cholesterol (TC), low density lipoprotein
cholesterol (LDL-C), aspartate transaminase (AST), and
alanine transaminase (ALT) of mouse treated by normal
diet or high fat diet for 16 or 38 weeks were assayed ac-
cording to the manufacturer’s instructions and results
obtained by microplate spectrophotometer. The blood
glucose levels were measured by using ROCHE Accu-
Chek Performa.
RNA preparation and sequencing
For each group, 5 out of 11 mice livers were randomly
picked for RNA sequencing. Total RNA was extracted
from mouse liver tissues according to following proce-
dures. Approximately 20 mg of liver tissues was homoge-
nized in 1 mL Trizol on ice, incubated at room
temperature for 5 min and added 200 μL chloroform.
After low temperature centrifugation, 500 μL isopropa-
nol was used to precipitate RNA. The precipitate was
washed with 75% ethanol (DEPC water configuration),
and then dissolved by 30 μL DEPC water after evapo-
rated all ethanol. RNA integrity was evaluated by Agilent
2100 Bioanalyzer (Agilent Technologies). RNA sequen-
cing was performed on an Illumina Hiseq 2000 platform
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(BGI, the Beijing Genomics Institute, https:// www.gen-
omics.org.cn).
The cDNA synthesis and quantitative real time PCR
Double-stranded complementary DNA (cDNA) was syn-
thesized from total RNA by using a PrimeScript RT re-
agent kit (Company, City, TaKaRa, Japan) on a
Mastercycler Gradient PCR Thermal cycler (Eppendorf
Scientific, Inc., Germany), according to the manufac-
turer’s instructions. Quantitative Real-time PCR was per-
formed by using 2*SYBR Green Supermix (Bio-Rad,
Germany). The RT-qPCR reactions were conducted on a
CFX96 RT-PCR System (C1000 Touch, BioRad,
Germany). Transcriptomic data were validated by per-
forming qRT-PCR on Cyp7a1 and Cyp8b1 to detect its
mRNA levels at four groups (ND16W, HFD16W, ND38W
and HFD38W). The expression of GAPDH was used as
the normalization control. The primers used were listed in
Table 1. The Pearson product-moment correlation coeffi-
cient (R) was used to evaluate the strength of association
between qRT-PCR and RNA-seq results.
Bile acids quantification
Hepatic bile acids homeostasis profiles of all mice in-
volved in the animal experiment were checked by the
ultra performance liquid chromatography coupled with
tandom mass spectrometry (UPLC-MS/MS) technology.
Approximately 100 mg of liver tissues was homogenized
in 300 μL acetonitrile on ice. The homogenates were
centrifuged at 14300 rpm and 4 °C for 10 min. Take the
supernatant 250 μL, which was evaporated under nitro-
gen gas flow nitrogen blowing dry and dissolved in
100 μL 50% methanol. Quantifications of BAs were per-
formed on a 6420 Triple Quad UPLC-MS/MS system
(Agilent 6420, Santa Clara, CA). An CQUITY UPLC
BEH C18 (1.7 μm, 100 × 2.1 mm) column was used for
BAs separation, eluting with acetonitrile and ammonium
acetate as the mobile phase. The chromatographic pa-
rameters were refered to the published method [11]. Pa-
rameters of the ESI ion source were as follows: Gas
Temp: 326 °C, Gas Flow: 12 L/min, Nebulizer: 55 psi, Ca-
pillary: 3500 V. The mass analyzer was set as the SIM
mode to capture the [M-H] − ions of expected BAs. Peak
areas of each observed BAs were used for comparison
and statistical analysis among groups.
Data process and mining
Variance analyses and significance tests were performed
using SPSS Statistics 18.0 (IBM, Chicago, USA). Statistic
methods were described in the figure legends. In the
present study, we generated a list of approximately 600
genes involved in DMPK systems, and this gene set has
been reported in NCBI database (https://www.ncbi.nlm.
nih.gov/). R program was used to visulize the expression
Table 1 Primers for real time PCR assays
Gene Forward primers Reverse primers
Cyp7a1 GAGCCCTGAAGCAATGAAAG GCTGTCCGGATATTCAAGGA
Cyp8b1 GGACAGCCTATCCTTGGTGA GACGGAACTTCCTGAACAGC
Cyp4a10 AATGGGAACGGCTGGCTGA TGGCCAAGCGGCCATTGGAA
Cyp4a14 GGCGAAAGAAAGTCAGGTT AGGCAGTGTTCAGTTGGA
Cyp4a31 AATGGGAACGGCTGGCTGGT TGGACAAGCGGCCATTGGA
Cyp2c70 TGGAGCCGGAACAGAGACAACGA ACGGCATGTGGTTCCTGTCCTGCA
Cyp3a59 CAGGCTAGAAAGGGTCTCAAAA AGTTTCATGCTGATGAGAGCAA
Gsta3 AGGAGTGGCGGATCTGGAGA CGGGTCCAGCTCTTCCACAT
Gstm6 GCCATGGTTTGCAGGGGACA TGGAAGGAAGCGGCTGGTCT
Gstm7 CCATGGTTCGCAGGGGACAA TTGCTGCCCCAAGTTGCCA
Nat8f1 ACAGCATCGAGGACAGGGGA GCCTGCCTTCTTGAAGCCCA
Slc22a30 GGAAGTATTATTTGTCTCCCATCG AGGATCCTACTGCCATTATCAGAG
Slc22a5 ACGAAGCCTCAGTTGCACCA ACAACAGCCAGGCCAGCACA
Slc30a10 GACTTTCATTTGCTGTGCTGAG GTGACAGGACATAAGGCAATGA
Slc4a4 CTTACAGAATCCCCAAGACTGG AAGTTGCATAGGAAAAGGGACA
Slco1a4 TACACGCTGGGTCGGTGCTT TCGGATTGCAGGAGAGGCT
Ugt2b35 GCCCTTGCCCAGATTCCACA AGAGTCCATTCGCGCCACCA
Cyp3a11 TGCCTTGGCATGAGGTTTGC TGACTGCATCCCGTGGCACA
Cyp2c70 TGGAGCCGGAACAGAGACAACGA ACGGCATGTGGTTCCTGTCCTGCA
Gapdh TGTGTCCGTCGTGGATCTGA CCTGCTTCACCACCTTCTTGA
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levels of all investigated DMPK gene expressions and
profile the global changes [12]. The heatmap was gener-
ated by using the “heatmap.2” function of the gplots
package in the R program [13]. Other figures were pre-
pared by the “ggplot” function of the “ggplot2” package
in the R program [14]. Principal component analysis
(PCA) was performed using the “pca” function of mixO-
mics package in the R program [15]. Before principal
component analysis, data was scaled based on gene.
Components number was set to be 2. Statistical signifi-
cance levels of data in Figs. 1, 5, and 6 were tesed by the
two-way ANOVA followed by a Tukey’s test, which were
done by using the base functions “aov” and “TukeyHSD”
in R program. In Fig. 2c and Fig. 3c, the statistical sig-
nificance levels of data were tested by the student t’test,
which was done by using the base function “t.test” in R
program.
Results
High fat diet changed lipid profiles in serum and liver tissues
Treatment with high fat diet for both 16 and 38 weeks
significantly increased serum total cholesterol level
(Fig. 1a), and low-density lipoprotein cholesterol level by
two-fold. In addition, blood glucose levels and body
weights were also induced. Meanwhile, hepatic injury
was present by the elevated levels of serum AST and
ALT (Fig. 1b). The HE staining showed an obvious accu-
mulation of fat in liver cells (Fig. 1c). All of those data
indicated that high fat diet made the lipids homeostasis
disordered and may accomany with liver injury.
Hepatic profiles of genes enriched in the hepatic DMPK
system
In the present study, we generated a list with genes in-
volved in DMPK systems. In total 612 genes were
Fig. 1 High fat diet changed lipid profiles in serum and liver tissues at week 38. a High fat diet significantly increased the serum total cholesterol
(TC), low density lipoprotein cholesterol (LDL), blood glucose (Glu), and body weight (BW) levels of mice at both week 16 and 38. b High fat diet
significantly increased the serum AST and ALT levels of mice at week 38. c Liver histopathology (HE, × 40) showing the fat accumulation in
hepatocytes of mice treated by high fat diet for 38 weeks. Abbreviation: ND, normal diet group; HFD, high fat diet group. Data were presented as
mean ± SEM. *p < 0.05 checked by the two-way ANOVA forllowed by the Tukey’s test
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collected. Based on this gene set, hepatic expression pro-
files of mice treated with high fat diet for 38 weeks were
obviously different from that treated with normal diet.
In heatmap (Fig. 2a), genes located in lower side showed
the similar expression pattern. These genes had higher
hepatic expression levels in mice treated with high fat
diet. In contrast, genes located in upper side showed
similar expression patters that mice treated with normal
diet had higher gene expression levels than high fat diet.
A principle component analysis (PCA) showed com-
pletely different location between mice treated with nor-
mal diet and high fat diet in score plots (Fig. 2b),
indicating that expression profiles of gene transcriptions
involved in DMPK systems were significantly affected by
high fat diet. Based on these gene expression data (Fig.
2c), we generated a volcano plot showing how these
genes were changed by high fat diet. Among all 612
genes, hepatic expression levels of 210 genes were
significantly altered. Among these 210 significantly regu-
lated genes, 64 genes were down regulated, while 146
genes were up regulated. If we considered the fold
change of the gene expression levels, 24 genes were
down-regulated by twice, while 39 genes were up-
regulated by twice.
To observe the favored expression level region regu-
lated by high fat diet, we used the data of 210 genes
which were significantly regulated by treatment of high
fat diet for 38 weeks. We plotted the fold change values
vs the basel expression levels of these 210 genes. The ba-
sel levels of these 210 genes distributed from FPKM
value of 0 to more than approximat 10,000. Genes en-
coding a couple major cytochrome P450 enzymes re-
sponsible for most xenobiotic metabolism, like Cyp3a11
and Cyp2e1, showed relatively high expression levels in
mice livers (Fig. 2d). The genes of Cyp4a10 and
Cyp4a14, which are responsible for fat metabolisms,
Fig. 2 Expression profiles of hepatic DMPK genes changed by treatment of high fat diet for 38 weeks. a Heatmap visualization. b Score plots of
principal component analysis. c Volcano plots showing the significantly regulated genes. Names of genes changed by more than 2 folds with
p < 0.01 were labled. The top and bottom horizontal line represent p values of 0.01 and 0.05, respectively; d Distribution of the expression levels
of genes significantly changed by treatment of high fat diet for 38 weeks. Names of genes with fold change values more than 5 or with basel
expression levels (FPKM) more than 1000 were labeled. Abbreviation: ND, normal diet group; HFD, high fat diet group
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were also highly expressed in mice livers. Interestingly,
most of these top expressed DMPK genes were signifi-
cantly affected by high fat diet. For example, gene ex-
pression level of Cyp4a14 was down regulated by more
than 35 times. Gene expression of Cyp3a11, an import-
ant xenobiotic metabolic enzyme, was down regulated
by more than 10 times. In contrast, although a large
amount of DMPK genes were significantly regulated
(Fig. 2c), genes with lower expression levels were not
regulated as sensitive as highly expressed Cyp3a11,
Cyp4a10, and Cyp4a14 (Fig. 2d). Regarding genes with
FPKM values less than 1000, only Slc22a7, Slco1a4,
Slc22a7, and Cyp51 were regulated by more than 5-fold.
Significantly regulated hepatic genes were enriched in
DMPK systems
Although more than 20,000 hepatic genes were detectable
by RNA-sequencing, most of them were expressed in the
livers at extremely low levels. The majority of hepatic genes
accumulated in the area with expression values (FPKM) less
than 100 (Fig. 3b). We assume that most of those genes are
silenced in physiological condition. Regarding genome wide
genes with FPKM values more than 100 (n = 679), high fat
diet treatment for 38 weeks regulated 11% of them (Fig. 3a,
top pan chart). However, if we changed the scale to DMPK
system, the percentage values increased to 30% (Fig. 3a,
bottom pan chart). To observe the enriched area of expres-
sion levels for genes regulated by high fat diet in both gen-
ome wide and DMPK scale, we plotted the distribution
frequency of gene number against the gene expression
levels represented by FPKM values. High fat diet did not
make a signicant change in both genome wide and DMPK
system scale (Fig. 3b). However, in the top 5 genes regu-
lated by high fat diet on the genome wide scale (in total 20,
521 genes), 3 out of them, including Cyp4a10, Cyp3a11,
and Cyp4a14, belong to the hepatic DMPK system (Fig.
3c), proving again that DMPK system is an import area in
the liver suffering from the pressure of high fat diet.
Fig. 3 Effect of high fat diet on DMPK system play an important role on its effect on the whole genome. a The percentage of genes significantly
changed by high fat diet at the transcriptional level. Top: whole genome wide scale; bottom: DMPK system. b Distribution frequency of hepatic
gene expression levels at the whole genome wide (gw) scale and DMPK system scale. Mice were treated for 0 day (day 0) or 38 weeks. . c Top
five HFD-repressed genes on the genome wide levelsData were presented as mean ± SEM. ***p < 0.001 checked by the student t-test. ND, normal
diet group; HFD, high fat diet group
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RT-PCR validation of a couple selected genes
Although the accuracy and precision of mRNA chips
and RNA sequencing were well accepted. In this study,
we still randomly picked a couple genes involved in hep-
atic DMPK system to check the expression levels by
traditional real-time PCR. The real-time PCR data and
the RNA-seq data referring to the same sample was
compared (Fig. 4). RNA seq data of all of the investi-
gated 16 genes showed a positive relationship with the
data accquired based on traditional real-time PCR tech-
nology. However, we also observed that, the correlation
between two technology is closer in high expression area
than low expression areas, indicating one of the tech-
nologies may more sensitive that the other one. As the
real-time PCR highly depend on the primer sequence,
we assume the RNA seq data is more reliable. Any way,
this comparison proved that the analysis could be
checked by more than one technology.
Effect of high fat diet on DMPK genes in mice with
different ages
In the present study, mice serum total cholesterol, low
density lipoprotein cholesterol, and blood glucose levels
were significantly induced at week 38. At this time point,
mice were relatively old. As we started the experiment
while mice were 8 weeks old. At week 38 of the experi-
ment, the mice were already 46 weeks old and could be
used as an aging model. To observe the gene regulation
profile by high fat diet in younger mice, we set the other
time point of week 16. Among all significantly regulated
DMPK genes at week 38, we picked 12 of them to test.
The 12 genes consist of members from CYP, UGT,
FMO, NAT, GST, SLC, SULT, ADH, and ALDH fam-
ilies, covering the most DMPK functions. Proteins
encoded by these 12 genes were responsible for xenobiotic
oxidation, conjugation, as well as transportation. Almost
all of them were regulated by high fat diet at a age-
Fig. 4 Validation of RNA-seq data by real-time PCR technology on 12 randomly selected genes involved in the drug metabolism and
pharmacokinetic system. Shadows means the confidential area of the trend lines
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dependent pattern (Fig. 5). Some of them, like Cyp3a11
and Ugt1a9, were constitutively repressed by high fat diet
treatment for both 16 weeks and 38 weeks. The fold
changes that high fat diet repressed them at week 38 were
apparently larger than that at week 16, however, fail to
pass the statistic chack. Some of them, like Slc22a7, Adh4,
and Nat8f1, were repressed by high fat diet at week 16,
however, were induced at week 38. Moreover genes in-
volving Slco1a4, Cyp4a10, Cyp8b1, Aldh1b1, and Gsta3,
were not regulated by high fat diet at week 16, however
were significantly induced or repressed at week 38.
High fat diet altered bile acids homeostasis in which lots
of DMPK genes were enriched
Mouse hepatic bile acids levels were determined by ultra
performance liquid chromatography coupled with tan-
dem mass spectrometry. Fourteen major hepatic bile
acids were quantified in mice treated by normal diet and
high fat diet for 16 and 38 weeks. Score plots of principle
component analysis clearly distinguished mice received
different treatments, as well as mice at different ages
(Fig. 6a). It indicated that high fat diet significantly chan-
ged hepatic bile acids homeostasis in both young and
old mice. The distance between old mice treated by high
fat diet and normal diet in score plots was obvious farer
than that between young mice treated by high fat diet
and young mice (Indicated by the arrows in Fig. 6a). It
showed hepatic bile acids homeostasis in old mice is more
sensitive to high fat diet than in young mice. Loading plots
suggested TCA as a significant marker contributing to
mice treated with normal diet for 38 weeks (Fig. 6b). One-
way ANOVA verified the statistic significance of the
higher TCA level in old mice treated with normal diet in
contrast to old mice treated with high fat diet, as well as
to young mice treated with normal diet (Fig. 6c). However,
high fat diet had no effect on TCA levels in young mice.
Bile acid TCDCA was not changed by high fat diet in both
Fig. 5 Time course of hepatic expression levels of 12 represented DMPK genes in mice treated by normal diet or high fat diet for 0 week, 16
weeks and 38 weeks. Abbreviation: ND, normal diet group; HFD, high fat diet group. Data were presented as mean ± SEM. a p < 0.05 between ND
and HFD groups at a specified time point. b p < 0.05 vs the previous time point with the same treatment. c p < 0.05 vs the week 0. All comparison
were checked by the two-way ANOVA followed by the Tukey’s test
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young and old mice livers, meanwhile, TDCA was altered
by both high fat diet treatment and aging.
Correlation analysis on the DMPK systematic level
Using gene expression levels and serum lipid levels in
mice treated with normal diet and high fat diet for both
16 and 38 weeks, a correlation analysis was conducted. A
heatmap showed that large numbers of genes were ether
positively (indicated by the red color, Fig. 7) or nega-
tively (green color) correlated with each other. Serum
total cholesterol levels were positively correlated with
serum LDL-C levels. Body weight was positively corre-
lated with blood glucose. These findings were consistent
with traditional opinions. Some were also identified from
the correlation analysis. For example, serum total choles-
terol levels were negatively correlated with hepatic gene
expression levels of Cyp3a11, however, positively corre-
lated with that of Gstk1. Mice body weight was positively
correlated with hepatic gene expression levels of
Cyp17a1, while negatively correlated with that of
Cyp3a11. Interestingly, transcription of Cyp3a11 was re-
pressed by high fat diet and showed opposite trend with
the mouse body weight, however, within the high diet
group or normal diet group, Cyp3a11 gene expression
levels were unexpectedly positively correlated with body
weight. In addition to the relationship between body
weight as well as serum lipid profiles and gene expres-
sions, correlation between genes were also observed. For
Fig. 6 Effect of high fat diet on the bile acids pathway. a Score plot of principal component analysis. b Loading plot of principal component
analysis. c TCA, TCDCA,TDCA levels. Abbreviation: ND, normal diet group; HFD, high fat diet group. Data were presented as mean ± SEM. *p < 0.05
checked by tne-way ANOVA followed by the Tukey’s test
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example, Cyp3a11 gene expression was positively corre-
lated with Ugt1a9 in liver.
Discussion
As the deficiency of global analysis of gene expression
profile of hepatic DMPK systems, the effect of high fat
diet on a lot of important DMPK genes was still not
known. In the present study, we filled some unknown
areas. Ugt1a9 encodes an enzyme responsible for hy-
droxyl and phenol glucuronidation. Substrates of
UGT1A9 involve lots of nature products such as flavo-
noids, tanshinone, and some alkaloids [16–19], as well as
important synthetic drugs such as propofol [20], 4-
methylumbelliferone [21], mycophenolic acid [22], and
morphine [23]. In addition, UGT1A9 also participated in
metabolism processes of endogenous signaling mole-
cules like estradiol [24]. In the present study, we showed
that Ugt1a9 was down regulated by high fat diet by more
than 3 folds. As drugs like propofol and mycophenolic
acid are extremely important for surgery anesthesia and
organ transplantation, respectively, dosages should be
adjusted when patients have long term of high fat diet
history. Except Ugt1a9, in the present study, we found
around 170 high fat diet regulated genes which have not
been reported before, including frequently studied CYP
and UGT families. For example, we observed a 5-folds
down-regulation of Fmo2 by high fat diet in the present
study. FMO family members are responsible for catalysis
of oxidation of nitrogen atom which is included in struc-
tures of lots of drugs. In addition, Fmo2 is an important
source of hydrogen peroxide, thus is important for
xenobiotic-induced toxicity [25]. Anti-tuberculosis drug
ethionamide is mainly metabolized by FMO. As ethion-
amide may induce acute liver injury, reduced gene ex-
pression of Fmo2 may associate with high safety issue if
the dosage was not adjusted in patients with high fat diet
history. Moreover, recent years, more peptide drugs have
been developed [26]. In the present study, we also ob-
served a couple high fat diet regulated genes responsible
for peptides metabolisms such as Nat8f1, Nat8f2, Mgst3,
and Gstm6. Metabolisms of peptide drugs are completely
different from traditional small molecular drugs. CYP
and UGT enzymes almost do not participate in the me-
tabolism processes of peptide drugs [27]. Nitrogen
Fig. 7 Correlation between serum lipids profile and DMPK gene expressions. Heatmap showed correlation between expression levels of genes
involved in drug metabolism and pharmacokinetic system. Line plots showed the correlation between expression levels of representative genes
and serum lipids as well as between each other of specific genes
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acetylation as well as peptide conjugations may play
much important roles. Nitrogen terminal acetylation
may improve the stability of peptides [28]. We observed
a 5-folds up-regulation of Nat8f1 by high fat diet in this
study. Thus, we assume that increasing the dosage of
peptides drugs in patients with high fat diet history is a
potentially valuable topic in clinical researches.
Different from traditional views, the biological func-
tions like DMPK are not determined by a couple specific
genes but a global system or even global systems. Many
nutritional statues,such as starvation and fasting, could
altere the pharmacokinetic characteristics of drugs,
among which high fat diet was the most common situ-
ation used in the experiment process [29]. In this study,
we have analyzed the transcriptome of mouse hepatic
DMPK system including in total 612 genes. The results
showed that mice treated with high fat or normal diet
displayed a different gene expression profile in a global
view. Among those 612 DMPK-involded genes, based on
the RNA-seq data, we have identified 146 up-regulated
and 64 down-regulated genes in high fat diet group as
compared to normal diet group, supporting the hypoth-
esis that high fat diet changed the DMPK system profile
but not only a couple specific genes.
As we were discussing the change of DMPK system by
high fat diet at the gene expression levels. We also want
to know some sign on the functional level. Regarding
DMPK, structure changes and transportation processes
are very important. In vitro, we could use some probes
to check. However, even though the in vivo probe exists
for a couple DMPK enzymes, defficence of probes for
most enzymes and transporters is still the problem.
Thus, we have to find a indirect way. The best way is the
usage of a endogenous metabolic network. In a certain
period following drug administration, the concentrations
of a drug and its metabolites in the circulating system
and target organs were controlled by drug metabolism
and transport in organs, such as liver, intestine and so
on [30]. The liver is the major organ for drug metabolic
processes, including phase I and II. In addition, large
and charged compounds are normally transported into
the hepatocytes and out into the bile by drug trans-
porters [31]. Enzymes and transporters participating in
these aforementiond processes are also frequently
enriched in the system controlling the bile acids homeo-
stasis. Although it is a known knowledge that high fat
diet changed the bile acids pool and profiles, the data
coming from the same sample sets maybe more accurate
for comparison. Results of the present study as well as
the reported work did support our hypothesis. Bile acids
homeostasis was significantly changed by high fat diet.
More important, same as the gene expression profile,
the change of bile acids homeostasis by high fat diet also
followed the age-dependent manner.
Cyp4a14 is an important gene coding the protein for
lipid oxidation. To data, Cyp4a14 was up regulated by
the high fat diet treatment in 26 weeks. However, 38
weeks after high fat diet treatment, we observed a dra-
matically down-regulation of this gene. It implies that
the regulation of DMPK genes may be time-dependent
or age-dependent. This is a very important finding indi-
cating the different regulation style of high fat diet on
DMPK system may exist in elder people from young
people. On the other hand, high-fat diet increases fatty
acid oxidation levels in mice [32]. As the high levels of
serum lipids still existed at week 38 of high fat diet treat-
ment, how to release the block of the transcription
process of lipid oxidation genes like Cyp4a14 is the po-
tential direction of drug development. Regarding
Cyp2e1, to data, this gene was up-regulated in mice
treated by a high fat diet of 8 weeks [33]. In the present
study, this gene was also induced by a high fat diet treat-
ment of 16 weeks, however, down-regulated of 38 weeks.
Cyp2e1 enzyme expresses in many tissues including liver
and other organs. It has an important role in oxidizing
various small molecule substrates such as alcohol, drugs,
solvents and fatty acids [34]. In addition, Cyp2e1 regula-
tion is affected by age, gender, genetic factors, nutrition,
hormones, and pathophysiological conditions such as
diabetes and obesity. The reports that Cyp2e1 levels are
regulated during aging, which was consistent with our
result [35].
CYP7A1 is a rate-limiting enzyme that converts chol-
esterol into bile acids in the liver, can contribute to
maintenance of mammalian cholesterol homeostasis
[36]. High fat diet treatment of 8 weeks repressed mRNA
level and protein level of Cyp7a1 in rat [37], consistent
with our result. However, in patient with NAFLD, the
trend is opposite [7]. Species difference may exist be-
tween rodents and humans.
In HFD/STZ-induced diabetes mice model, mRNA level
of Cyp8b1 was induced [38]. However, a high fat diet
treatment unique showed a down-regulation trend on
Cyp8b1 [33]. Cyp8b1 was a key enzyme in the bile acid
formation pathway. Our study shows that high fat diet
mice were inhibited expression of Cyp8b1 and Cyp7a1.
Cholesterol catabolism into bile acids was inhibited, which
caused the cholesterol elevated cholesterol [39].
Cyp3a11 is a mouse homolog of Cyp3a4. It has been re-
ported that hepatic Cyp3a11 expression decreased after
high fat diet feeding in mice. This is in line with previous
reports11. The strong inverse correlation between RNA
expression of Cyp3a11 and serum TC or body weight im-
plicate that high fat diet may directly reduced RNA levels
of the hepatic Cyp3a11 enzymes compared to normal diet
mice. Cyp3a11 participates in the metabolisms of hypnotic
drug midazolam. The prolonged sleep time induced by
the experimental midazolam in high fat diet mice
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indicates a decrease in the expression of Cyp3a11, demon-
strating that the presence of a high-fat diet is indeed
reflected in its pharmacodynamics [40]. Therefore,
dosages should be adjusted when patients have long
term of high fat diet history taking hypnotics.
Cyp17a1 has 17,20-lyase activity, which determines
the final product of steroid hormone biosynthesis.
Studies have reported that 17,20-lyase activity leads to
androgen, whereas 17-hydroxylase activity of Cyp17a1
is necessary to produce glucocorticoid cortisol [41].
The positive correlation of seen Cyp17a1 gene and
body weight in the present study may imply that
Cyp17a1 can contribute to the development of meta-
bolic syndrome. In addition, Our studies showed that
high fat diet mice, the down-regulation genes included
Cyp8b1, Cyp7a1, sult3a1, Sulte1, Gstt3, Cyp51, Cyp2c54
and Cyp4f14, and the up-regulation genes included
Cyp17a1, Cyp3a41a, Asns, Past1, Cyp2c55, Gstm2 and
Gstaα1. Studies suggested that besides Cyp17a1, Cyp3a41a
were opposite, others consistent with literature [33].
A similar study has investigated the high fat diet effect
on rats hepatic DMPK system at the transcriptional level
[42]. In a 12-weeks treatment by using high fat diet, a
couple mice hepatic phase I and phase II metabolic en-
zymes as well as some transporters were down-regulated
at the transcriptional level. In the present study, we
found a consistent trend in a 16-weeks treatment by
high fat diet on genes such as Cyp1a2, Cyp3a11
(Cyp3a1/2 in rats), Cyp4a12, Ugt1a1, Ugt1a6, Ugt1a9,
Ugt2b1, and Gstt1. However, at week 16, high fat diet
did not regulate the expression levels of mice hepatic
genes Slco1a2, Slco1b2, Slc22a5, Abcc2, Abcc3, Abcb1a,
and Abcg2 which were down-regulated in the reported
12-weeks treatment of rats by high fat diet. As some im-
portant genes showed the same trends in our study as
the reported data, the significant role of high fat diet on
the regulation of DMPK system was confirmed again. As
the experiment parameters were not completely
matched between the present study and the rat experi-
ments, the different regulation style of some other genes
was acceptable. At first, species are diffent. A couple
DMPK genes in mice and rats are not the same as each
other. Secondly, mice were treated by high fat diet one
more week in the present study than rats in the afore-
mentioned paper. Finaly, we used normal diet as the
control but low-fat diet was used as the control in rats
experiment. However, both researches indicated that
species differnce was worth to study on the effect of high
fat diet on DMPK system.
Conclusions
High fat diet changed the global profile of hepatic gene
transcription of the drug metabolism and pharmacoki-
netic system but not only a couple specific genes
involved. The impact of high fat diet on drug metabol-
ism system was more serious than on the whole genome.
The effect of high fat diet on the effect of high fat diet
on DMPK gene transcription showed an age-dependent
or feeding-duration-dependent style. It is worthable to
watch the medicine dosage in patients with high fat diet
history in the futher clinical researches.
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